✦ LIBER ✦

Mortality in Men Treated With Radiation Therapy and Androgen Deprivation for High-risk Prostate Cancer in the Modern Era is Driven by Non-prostate Cancer Deaths

✍ Scribed by Tendulkar, R.D.; Hunter, G.K.; Reddy, C.A.; Stephans, K.L.; Ciezki, J.P.; Stephenson, A.J.; Klein, E.A.; Mahadevan, A.; Kupelian, P.A.

Book ID: 122988287
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 77 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.247

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Percent Positive Biopsy Cores and the Ri

Percent Positive Biopsy Cores and the Risk of Death from Prostate Cancer in Men Treated with Radiation and Androgen Deprivation Therapy

✍ Phillips, J.; Chen, M.; Zhang, D.; Loffredo, M.; Kantoff, P.; D'Amico, A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Androgen Deprivation Therapy in Patients

Androgen Deprivation Therapy in Patients Treated with External Beam Radiotherapy for High-risk Prostate Cancer in the PSA Era

✍ A.D. Vassil; E.S. Murphy; C.G. Robinson; C.A. Reddy; N. Chehade; J.P. Ciezki 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Pretreatment prostate-specific antigen v

Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy

✍ David Palma; Scott Tyldesley; Tom Pickles; for the Prostate Cohort Outcomes Init 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

## Abstract ## BACKGROUND In men with prostate cancer, pretreatment prostate‐specific antigen (PSA) velocity (PSAV) has been demonstrated as a predictor of biochemical and survival outcomes in patients undergoing radical prostatectomy (RP). The utility of pretreatment PSAV in predicting outcomes a

The addition of low-dose-rate brachyther

The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer

✍ Mark Shilkrut; Gregory S. Merrick; P. William McLaughlin; Matthew H. Stenmark; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

PSA Response to Neoadjuvant Androgen Dep

PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era

✍ Sean E. McGuire; Andrew K. Lee; Jasmina Z. Cerne; Mark F. Munsell; Lawrence B. L 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 315 KB

885 AVOIDING ANDROGEN DEPRIVATION THERAP

885 AVOIDING ANDROGEN DEPRIVATION THERAPY IN MEN WITH HIGH RISK PROSTATE CANCER: THE ROLE OF RADICAL PROSTATECTOMY AS INITIAL TREATMENT

✍ Miocinovic, Ranko; Berglund, Ryan K.; Stephenson, Andrew J.; Jones, J. Stephen; 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 154 KB